Atlas Trials

Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells

Clinical trial NCT03046407 · UNKNOWN

Trial details

NCT number
NCT03046407
Sponsor
Chinese Academy of Sciences
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dry Age-related Macular Degeneration
Start date
2017-09-06
Primary completion
2019-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.